| ID | Name | CAS | Properties |
MW (g/mol) |
| 66-773-1 |
6'-Galactosyl-lactulose: bD-Galp(1->6)-bDGalp(1->4)-DFru, oxime-TMS, isomer # 2
|
|
2 | 1385.63 |
| 66-855-0 |
(Z)-10-Dodecenoic acid, 9,12-dioxo, methyl ester, «omega»-PFB-oxime, TMS-enol, # 1
|
|
2 | 507.57 |
| 66-890-1 |
d-Glucose, 2,3,4,5,6-pentakis-O-(trimethylsilyl)-, o-methyloxyme, (1E)-
|
130405-10-6 |
2 | 570.10 |
| 66-915-3 |
ent-16«beta»,17-H2(OH)2 6«alpha»,7«alpha»(OH)2 kaurenoic acid, MeTMSi
|
|
2 | 671.22 |
| 67-170-9 |
5.alpha.-Pregnane-11,20-dione-3.alpha.,21-diol, EO-TMS, # 1
|
|
2 | 564.96 |
| 67-172-7 |
5.beta.-Pregnane-11,20-dione-3.alpha.,21-diol, EO-TMS, # 2
|
|
2 | 564.96 |
| 67-238-4 |
6'-Glucosyl-gentobiose: aD-Glcp(1->6)-bDGlcp(1->6)-DGlc, oxime-TMS, isomer # 2
|
|
2 | 1385.63 |
| 67-291-5 |
5«beta»-Androstan-6«beta»-ol-3,17-dione,tris-TMS
|
|
2 | 520.97 |
| 67-385-1 |
5-Cholesten-3-.beta.,7-.alpha.,12-.alpha.,25,26-pentol, TMS
|
|
2 | 811.58 |
| 67-452-6 |
Kojitriose: aD-Glcp(1->2)-aDGlcp(1->2)-DGlc, oxime-TMS, isomer # 1
|
|
2 | 1385.65 |
| 67-464-3 |
1,7-Di(2-methylbutyl)-2,2,4,4,6,6-hexamethyl-1,3,5,7-tetraoxa-2,4,6-trisilaheptane
|
|
2 | 380.74 |
| 67-489-6 |
1,6-Anhydro-2,3-O-isopropylidene-«beta»-D-mannopyranose, trimethylsilyl ether
|
|
2 | 274.39 |
| 67-558-9 |
ent-7«alpha»,16«beta»,17-tri-(OH)-16,17-dihydrokaurenonic acid, Me-TMS
|
|
2 | 583.03 |
| 67-643-4 |
7«alpha»,12«alpha»-dihydroxy, 3-oxy-5«beta»-cholanoate, methyl ester-trimethylsilyl ether
|
|
2 | 637.13 |
| 67-657-9 |
ent-7«alpha»,16«beta»,17-tri-(OH)-16,17-dihydrokaurenolide, Me-TMS
|
|
2 | 566.99 |
| 67-666-9 |
9,10-epoxy-18-hydroxyoctadecanoic acid, TMSi ester TMSi ether
|
|
2 | 458.83 |
| 67-679-5 |
1,3,5(10)-Oestratriene-2-methoxy-3,16«alpha»,17«beta»-triol, 3-TBDMS-16,17-TFA
|
|
2 | 624.68 |
| 67-682-1 |
3«alpha»,6«beta»,7«alpha»,12«beta»-Tetrahydroxy-5«beta»-cholanoic acid, MeTMS
|
|
2 | 727.32 |
| 67-734-3 |
N-Acetyl-D-glucosamine, tetrakis(trimethylsilyl) ether, trimethylsilyloxime (isomer 2)
|
|
2 | 597.13 |
| 67-996-3 |
cis-Phenanthrene, 9,10-dihydro-9-methyl-9,10-diol, 3-methoxy, methylboronate
|
|
2 | 280.13 |
| 68-130-2 |
Glycine, N-(2-methyl-1-oxo-2-butenyl)-, trimethylsilyl ester, (E)-
|
55517-35-6 |
2 | 229.35 |
| 68-208-6 |
9-Dodecyn-1-ol, dimethyl(dimethyl(pyrid-3-ylmethoxy)silyloxy)silyl ether
|
|
2 | 421.72 |
| 68-340-9 |
5-«beta»-Pregnan-20-«beta»-ol-3,11-dione, MO-TMS
|
|
2 | 462.74 |
| 68-352-6 |
2,4-Imidazolidinedione, 1,3-bis(chloromethyl)-5,5-dimethyl-
|
116401-49-1 |
2 | 225.07 |
| 68-385-0 |
Androst-16-ene, 3,17-bis[(trimethylsilyl)oxy]-, (3«alpha»,5«beta»)-
|
57305-19-8 |
2 | 434.81 |
| 68-395-9 |
Inulotriose: bD-Fruf(2->1)-bDFruf(2->1)-DFru, oxime-TMS, isomer # 2
|
|
2 | 1256.35 |
| 68-487-7 |
Methyl .alpha.-D-glucopyranose, 3,4-bis-O-pentyloxymethyl ether, TMS
|
|
2 | 538.87 |
| 68-619-0 |
5-«beta»-Pregnan-11-«beta»,20-«alpha»-diol-3-one, MO-TMS
|
|
2 | 507.90 |
| 68-633-4 |
3-«alpha»,4-«beta»,7-«alpha»,12-«alpha»-Tetrahydroxy-5-«alpha»-cholanoic acid, MeTMS
|
|
2 | 727.32 |
| 68-726-1 |
5-Amino-2-methoxyphenol, N-tert-butyldimethylsilyl-, tert-butyldimethylsilyl ether
|
|
2 | 367.67 |
| 68-804-4 |
Imidazole-4-carboxylic acid, 5-(3-cyclohexyl-3-methyl-1-triazeno)-, 2-(diethylamino)ethyl ester
|
36142-60-6 |
2 | 350.46 |
| 68-810-7 |
5«alpha»-Androstan-3«alpha»,17«beta»-diol, allyl-DMS
|
|
2 | 488.89 |
| 68-917-9 |
Acetic acid, [3-(1,2,3,4-tetrahydro-2,4-dioxo-5-pyrimidinyl)ureido]- ethyl ester
|
7154-16-7 |
2 | 256.22 |
| 69-036-6 |
S-Triazolo(1,5-A)pyrimidine, 5-methyl-7-ethylamino-
|
|
2 | 177.21 |
| 69-096-0 |
3,18-Dioxo-11«beta»,17«alpha»-dihydroxy-4-etienic acid, 20,18-lactone, 18,11-hemiacetal, MO-TMS
|
|
2 | 445.62 |
| 69-122-0 |
17-«alpha»-Methyl-5-«beta»-androst-1-ene-3-«alpha»,17-«beta»-diol, per-TMS
|
|
2 | 448.83 |
| 69-177-0 |
Urea, 1-methyl-1-nitroso-3-[2-(9h-purine-6-ylthio)ethyl]-
|
90642-35-6 |
2 | 281.29 |
| 69-198-7 |
3«alpha»,16«alpha»,17«beta»-Trihydroxy'5«beta»-androstan-11-one, tris-TMS
|
|
2 | 538.98 |
| 69-310-1 |
3-Aminobenzoic acid, N- trifluoroacetyl -, N,O-bis(tert.-butyldimethylsilyl)-
|
|
2 | 461.67 |
| 69-323-7 |
Ethyl (6S,7R)-8-azido-7-tert-butyldimethylsilyloxy-6-hydroxy-oct-2-enoate
|
|
2 | 357.52 |
| 69-407-4 |
3B-Hydroxy-androstan-5-en-17-one, enol, bis-TMS
|
|
2 | 446.77 |
| 69-535-2 |
5«beta»-Pregnane-3«alpha»,17«alpha»,20«alpha»-triol, (3,20-O)-diTMTBSi, (17-O)-TMSi
|
|
2 | 689.29 |
| 69-598-3 |
3,7,12-Trihydroxy-5-cholenoic acid, methyl ester, TMS
|
|
2 | 637.13 |
| 69-667-6 |
5«beta»-Androst-1-ene-3«alpha»,17«beta»-diol,bis-TMS
|
|
2 | 434.80 |
| 69-668-5 |
5«beta»-Androst-1-ene-3«beta»,17«beta»-diol,bis-TMS
|
|
2 | 434.80 |
| 69-755-8 |
5«alpha»-Androst-2-en-3,17«beta»-diol, (3,17-O-)-diTMSi
|
|
2 | 434.80 |
| 69-843-0 |
Cholanic acid, 3«alpha»,7«beta»,12«alpha»-trihydroxy, Me-DMES
|
|
2 | 681.22 |
| 69-849-4 |
Arabino-hexaric acid, 2-deoxy-3,4,5-tris-O-(trimethylsilyl)-, bis(trimethylsilyl) ester
|
38165-98-9 |
2 | 555.04 |
| 69-858-4 |
13,14-Dihydro-15-keto-PGE2, EO-TMS, isomer # 2
|
|
2 | 582.96 |
| 69-859-3 |
13,14-Dihydro-15-keto-PGE2, EO-TMS, isomer # 1
|
|
2 | 582.96 |
| 69-860-1 |
13,14-Dihydro-15-keto-PGE2, EO-TMS, isomer # 4
|
|
2 | 582.98 |
| 69-861-0 |
5«beta»-Androst-1-ene-3,17-dione,bis-TMS
|
|
2 | 430.77 |
| 69-892-6 |
Chromium, hexacarbonylbis(«eta»5-2,4-cyclopentadien-1-yl)di-, (Cr-Cr)
|
12194-12-6 |
2 | 402.24 |
| 70-010-2 |
5.beta.-Pregnane-20-one-3.alpha.,21-diol, TMSO-TMS, # 1
|
|
2 | 552.04 |
| 70-016-6 |
dl-5-Hydroxylysine, N,N,O-tris(trimethylsilyl)-, trimethylsilyl ester
|
|
2 | 450.91 |
| 70-047-2 |
(20R/S)-3.beta.,29-bis-(Trimethylsilyoxy)lupan-29-oate, # 1
|
|
2 | 603.09 |
| 70-124-6 |
3«beta»,16«alpha»-dihydroxy-5«alpha»-androstan-17-one, MO-TMS
|
|
2 | 538.00 |
| 70-131-8 |
Iron, di-«mu»-carbonyldicarbonylbis(«eta»5-2,4-cyclopentadien-1-yl)di-, (Fe-Fe)
|
12154-95-9 |
2 | 353.92 |
| 70-239-9 |
7«alpha»,12«alpha»-dihydroxy-3-oxy-4-chol-24-oate, O-methyloxime-TMS
|
|
2 | 650.12 |
| 70-289-4 |
7«alpha»,12«alpha»-dihydroxy-3-oxy-4-chol-24-oate, O-methyloxime (1)
|
|
2 | 650.12 |
| 70-322-6 |
13,14-Dihydro-15-keto-PGF1A, BO-TMS, isomer # 1
|
|
2 | 644.18 |
| 70-356-9 |
4-Pregnen-11-«beta»,20-«beta»-diol-3-one, MO-TMS
|
|
2 | 505.88 |
| 70-359-6 |
Silane, [[(3«beta»,5«alpha»,17«beta»)-androstane-3,17-diyl]bis(oxy)]bis[(1,1-dimethylethyl)dimethyl-
|
57711-47-4 |
2 | 520.98 |
| 70-480-1 |
24-Nor-5«beta»-cholane-3«alpha»,7«alpha»,12«alpha»,23-tetrol, TMS
|
|
2 | 669.29 |
| 70-481-0 |
Butanedioic acid, 2,3-bis[(trimethylsilyl)oxy]-, bis(trimethylsilyl) ester, (R*,S*)-
|
38165-94-5 |
2 | 438.82 |
| 70-500-8 |
15(S)-15-Methyl-PGA2, EO-TMS, isomer # 1
|
|
2 | 535.92 |
| 70-504-4 |
3-«alpha»,7-«alpha»,12-«alpha»-Trihydroxy-5-«beta»-cholestanoic acid, methyl ester, TMS
|
|
2 | 681.22 |
| 70-563-9 |
13,14-Dihydro-15-keto-TxB2, BO-TMS, isomer # 1
|
|
2 | 658.16 |
| 70-606-1 |
L-(+)-Tartaric acid, bis(trimethylsilyl) ether, bis(trimethylsilyl) ester
|
|
2 | 438.82 |
| 70-607-0 |
2-Glucosyl-cellobiose: aD-Glcp(1->2)-bDGlcp(1->4)-DGlc, oxime-TMS, isomer # 1
|
|
2 | 1385.63 |
| 70-609-8 |
13,14-Dihydro-15-keto-PGE2, BO-TMS, isomer # 2
|
|
2 | 639.08 |
| 70-610-6 |
13,14-Dihydro-15-keto-PGE2, BO-TMS, isomer # 1
|
|
2 | 639.08 |
| 70-611-5 |
13,14-Dihydro-15-keto-PGE2, BO-TMS, isomer # 4
|
|
2 | 639.08 |
| 70-619-7 |
2H-1-Benzopyran, 3,4-dihydro-2-[3,4-bis[(trimethylsilyl)oxy]phenyl]-3,5,7-tris[(trimethylsilyl)oxy]-, (2R-trans)-
|
64138-54-1 |
2 | 651.17 |
| 70-658-4 |
5«alpha»-Pregnane-3«alpha»,11«beta»,20«alpha»-triol, EO-TMS
|
|
2 | 539.03 |
| 70-690-8 |
3A,11B,17A,21-Tetrahydroxy-5A-pregnan-20-one, MO TMS
|
|
2 | 684.26 |
| 70-720-4 |
Pentanoic acid, 4-hydroxy-2-propyl, bis-TMS, # 1
|
|
2 | 304.58 |
| 70-732-1 |
5-Pregnen-3-«beta»,20-«alpha»-diol-11-one, MO-TMS
|
|
2 | 505.88 |
| 70-733-0 |
13,14-Dihydro-15-keto-TxB2, BO-TMS, isomer # 3
|
|
2 | 658.16 |
| 70-768-2 |
D-(+)-Glucuronic acid «gamma»-lactone, tris(trimethylsilyl) ether, benzyloxime (isomer 2)
|
|
2 | 497.80 |
| 70-783-5 |
13,14-Dihydro-15-keto-PGE2, MO-TMS, isomer # 2
|
|
2 | 554.92 |
| 70-791-6 |
Galactotriose: aD-Galp(1->3)-bDGalp(1->4)-DGal, oxime-TMS, isomer # 1
|
|
2 | 1385.63 |
| 70-807-8 |
Cellotriose: bD-Glcp(1->4)-bDGlcp(1->4)-DGlc, oxime-TMS, isomer # 1
|
|
2 | 1385.63 |
| 70-808-7 |
Cellotriose: bD-Glcp(1->4)-bDGlcp(1->4)-DGlc, oxime-TMS, isomer # 2
|
|
2 | 1385.63 |
| 70-828-5 |
4-Pregnen-11«beta»,17«alpha»,21-triol-3,20-dione, MO-tris-TMS
|
|
2 | 637.09 |
| 70-830-2 |
5.alpha.-Pregnane-11,20-dione-3.alpha.,21-diol, TMSO-TMS, # 1
|
|
2 | 653.22 |
| 70-841-0 |
5«beta»-Androstan-3«beta»-ol-17-one, allyl-DMS
|
|
2 | 486.88 |
| 70-842-9 |
5«alpha»-Androstan-3«beta»-ol-17-one, allyl-DMS
|
|
2 | 486.88 |
| 70-843-8 |
5«beta»-Androstan-3«alpha»-ol-17-one, allyl-DMS
|
|
2 | 486.88 |
| 70-866-3 |
5-«beta»-Pregnan-3-«alpha»-ol, 20-«alpha»-GlcNAc MeTMS
|
|
2 | 812.43 |
| 70-867-2 |
5-«alpha»-Pregnan-3-«alpha»,20-«alpha»-diol-20-GlcNAc TMS, # 2
|
|
2 | 812.43 |
| 70-868-1 |
5-«alpha»-Pregnan-3-«alpha»,20-«alpha»-diol-20-GlcNAc TMS, # 1
|
|
2 | 812.43 |
| 70-869-0 |
5-«beta»-Pregnan-3-«alpha»,20-«alpha»-diol-20-GlcNAc TMS, # 1
|
|
2 | 812.43 |
| 70-870-8 |
5-«alpha»-Pregnan-3-«alpha»-ol, 20-«alpha»-GlcNAc, MeTMS
|
|
2 | 812.43 |
| 70-895-1 |
(E)-10-Dodecenoic acid, 9-hydroxy-12-oxo, methyl ester, MSTFA-adduct, OH-TMS, # 1
|
|
2 | 513.75 |
| 70-912-1 |
5.alpha.-Pregnane-11,20-dione-3.alpha.,21-diol, MO-TMS, # 1
|
|
2 | 536.91 |
| 70-913-0 |
5.beta.-Pregnane-11,20-dione-3.alpha.,21-diol, MO-TMS, # 2
|
|
2 | 536.91 |
| 70-914-9 |
5.beta.-Pregnane-11,20-dione-3.alpha.,21-diol, MO-TMS, # 1
|
|
2 | 536.91 |
| 70-944-6 |
15(S)-15-Methyl-PGA2, MO-TMS, isomer # 2
|
|
2 | 521.88 |
| 70-947-3 |
3«alpha»,7«alpha»,12«alpha»-trihydroxy, 5«beta»-cholestanoate, methyl ester-trimethylsilyl ether
|
|
2 | 681.22 |
|
« Previous Results
Next Results »
|